Background. Asymptomatic Plasmodium falciparum infections are common in Malawi; however, the implications of these infections for the burden of malaria illness are unknown. Whether asymptomatic infections eventually progress to malaria illness, persist without causing symptoms, or clear spontaneously remains undetermined. We identified asymptomatic infections and evaluated the associations between persistent asymptomatic infections and malaria illness.
Asymptomatic Plasmodium falciparum infections are common in malaria-endemic regions [1] . However, the relationship of asymptomatic infection to malaria illness is unknown. Asymptomatic infections may develop into illness, or remain asymptomatic and untreated. Because asymptomatic infections can serve as a reservoir to mosquitoes, they may be important contributors to transmission and pose a public health challenge.
Programs to identify and treat all infected individuals or to distribute antimalarial medication through mass drug administration have been suggested as interventions designed to interrupt transmission by removing asymptomatic reservoirs. However, treating all asymptomatic infections could have negative consequences, including increased rates of malaria illness.
In some studies, individuals with asymptomatic infections were protected against development of malaria illness [2] [3] [4] [5] , and clearing asymptomatic infections led to an increased risk of malaria illness [2, 6] . If asymptomatic infections provide protection against malaria illness, treating asymptomatic infections could increase the likelihood of a subsequent infection evolving to disease [7] .
However, in some populations, particularly children under 3 years of age, evidence suggests that asymptomatic infections can be precursors to malaria illness [5, 8] . If so, treating and preventing asymptomatic infections could improve long-term health, while simultaneously removing sources of infection in the community. The frequency with which persistent infections lead to clinical illness has not been examined, and there are no previous studies on these questions that include longitudinal assessments of asymptomatic infection carriage in all ages with long-term follow-ups.
This study aimed to characterize asymptomatic infections in a region of Malawi with high perennial P. falciparum transmission [9] , and to examine the association between persistent asymptomatic infections and malaria illness. We prospectively assessed the temporal association between asymptomatic P. falciparum carriage and appearance of malaria illness, as well as between persistent infections and malaria illness, in a cohort aged 1 to 50 years.
METHODS

Participants
We enrolled 120 subjects seeking treatment for uncomplicated malaria at the Mfera Health Centre in the Chikhwawa district between June 2014 and March 2015. Subjects were eligible if they had a symptomatic P. falciparum infection-detected by rapid diagnostic test (RDT) to detect histidine-rich protein-2 and confirmed by microscopy-and were human immunodeficiency virus-negative at the time of screening. Subjects were excluded if, at screening, they had an acute non-malarial illness, signs of a severe illness, or were taking a medication with antimalarial activity. To be included in analyses, a subject had to have at least 1 follow-up visit 2 or more weeks after enrollment.
Study Procedures
Participants were treated with artemether-lumefantrine at enrollment, followed for 2 years with monthly routine visits, and encouraged to attend a clinic in the event of an illness. At each visit, blood spots on filter paper and thick blood smears were made, and participants were asked about any medical treatment administered outside of the study clinic. If participants reported symptoms indicative of malaria, an RDT was performed; when positive, participants were treated with a 3-day course of artemether-lumefantrine, per the Malawi national protocol.
Laboratory Procedures
Blood smears on slides were examined by 2 microscopists to determine the presence of Plasmodium parasites and quantify parasitemia. Discordant results were evaluated by a third reader, and samples with at least 2 positive reads were classified as positive. Duplicate real-time polymerase chain reaction (PCR) of P. falciparum DNA was done targeting the lactate dehydrogenase gene [10] .
DNA for genotyping was extracted from dried filter-paper blood spots [11] . Genotypes were differentiated by 3 highly polymorphic regions of the P. falciparum genome: 2 merozoite surface proteins (MSP1 and MSP2) and 1 glutamate-rich protein (GLURP) [12] . PCR products were run on polyacrylamide gels; band sizes were read by 2 independent readers, and by a third reader in cases of discrepancies. Samples of 2 genotypes were considered the same if alleles matched in at least 2 of the 3 regions and amplicon length was within 10 base pairs. Samples were considered to be multi-clonal if more than a single band was detected for any locus.
Definitions
Asymptomatic infection was initially classified when there was evidence of P. falciparum parasites from blood smear or PCR and no symptoms of malaria were reported at that time. This was changed to a definitive classification of asymptomatic infection if malaria illness did not occur during the subsequent 2 weeks and if no antimalarials were taken <2 weeks before the asymptomatic infection was detected. Malaria illness was defined as an illness reported by the participant with symptoms suggestive of malaria (including fever, headaches, musculoskeletal pain, and vomiting) and confirmed with a positive RDT. Participants with symptoms who were both RDT-and microscopy-negative, but PCR-positive, were considered to have asymptomatic infections, and symptoms were assumed to be attributable to a non-Plasmodium cause. RDT-negative, microscopy-positive events were rare (n = 6) and were classified as asymptomatic infections, as they were not treated.
A genotype was defined as persistent when participant samples obtained at different clinic visits contained the same alleles at 2 or 3 loci. Starting 2 weeks after a given genotype was identified, the Plasmodium infection type was classified in 1 of 3 ways: "all persistent" if the sample contained only previously detected genotypes, "all new" if it contained only genotypes that had not been detected in previous infections, or "new and persistent" if it contained both new genotypes and persistent genotypes.
Statistical Analysis
The covariates included in the analysis-age, sex, and seasonwere chosen a priori based on causal assumptions. Age was examined as a linear variable, and then various categorizations were explored. Based on the data, the following 3 categories were chosen: under 5 years, school-aged children (5 through 15 years; SAC), and adults (over 15). Season was defined as the season at beginning of each observation and classified as either rainy (December through April) or dry (May through November).
We carried out 2 distinct analyses that evaluated: (1) the relationship between carriage of an asymptomatic infection and time to malaria illness and (2) the relationship between persistent infection and the odds of malaria illness.
Time (days) was the outcome of interest in the first analysis. Subjects were grouped by presence or absence of detected asymptomatic infection before the occurrence of the outcome or censoring. Asymptomatic infections were subdivided into (1) multiclonal or single clonal infections and (2) microscopic or sub-microscopic infections. Participants were considered not at risk for malaria illness if they reported current malarial symptoms or were within 2 weeks of antimalarial treatment (protection from new Plasmodium infection reportedly lasts for at least 14 days [13] ). Follow-up time ended either at the beginning of the next treatment episode or when the subject was censored at end of follow-up. Individuals with multiple malaria episodes during the study period contributed multiple observations to the analysis, which were accounted for using frailty models.
Crude analyses of median time to malaria illness were calculated after each treatment episode using Kaplan-Meier curves. Time to malaria illness was compared between exposure groups using the log-rank test. Log-rank tests were also used to test bivariate associations between covariates of interest and time to malaria illness. Bivariate associations between covariates and exposure groups were tested using Chi-squared tests (all covariates were categorical).
To account for correlations between repeated observations from the same person, Cox models included subject as a random effect (ie, frailty models). For final models, presence of asymptomatic infection was included as a time-varying covariate, because many asymptomatic infections were detected after the beginning of follow-up, and at different times. To accomplish this, follow-up time was classified as the number of infection-free days until 2 weeks before the first asymptomatic infection was detected; after detection of an asymptomatic infection, all follow-up time was classified as asymptomatically infected. Proportional hazards were tested by comparing log-negative, log-survival plots, and by including an asymptomatic infection*time interaction term in the adjusted models. Akaike Information Criterion was used to select between exponential or Weibull distribution for the baseline hazard function. Age was assessed as an effect measure modifier by including an interaction term for age category*asymptomatic infection in models.
The analysis of the relationship between persistent or new infections and the odds of malaria illness included data on samples in which P. falciparum was identified by either blood smear or PCR and genotyping was successful. Samples from asymptomatic infections taken within 2 weeks of a malaria illness were not included. The outcome of interest was the odds of an infection being symptomatic. Chi-squared tests were used for preliminary analyses for the association between infection type at a given visit and the presence of malaria illness at the same visit, and to test for association between covariates and infection type and association between covariates and symptomatic (vs. asymptomatic) infections. Odds ratios were calculated with infection type grouped in 2 ways. First, "all persistent" infections were compared to "any new" infections, which was defined as the combination of the "all new" and the "new and persistent" infection categories. Second, "all new" infections were compared to "any persistent" infections, which was defined by pooling together the "all persistent" and the "new and persistent" categories. For final analyses, mixed-effect logistic regression was used to compare the log(odds) of symptoms for all persistent infections to any new infections, accounting for repeated measures within individual people. Final models included an interaction term for age*infection type. All statistical analyses were performed using SAS 9.3 (SAS Institute Inc., Cary, NC).
RESULTS
Participant and study characteristics of 114 individuals are summarized in Table 1 . Median follow-up time was 720 days (IQR = 715, 721), with no difference by sex or age. Participants had a median of 37 visits (IQR = 29, 45) and reported frequently to the health center for any-cause sick visits, with only 10 reports of outside care-seeking for malaria symptoms.
Association Between Asymptomatic Infection and Time Between Malaria Illness
Among 114 participants, 100 (88%) were treated for malaria illness (median = 3 malaria illness episodes per person, IQR = 1, 5). Geometric mean parasite density at malaria illness was 14 001/µl (SD = 1437). The median time between malaria illness episodes was 106 days ( Table 2) . Among asymptomatic infections, time to next malaria disease was not associated with number of clones present or microscopic detectability(Table 2, Figure 1 ). Neither clonality of asymptomatic infections nor microscopic detectability of asymptomatic infections was associated with time to next malaria illness (Table 2, Supplementary Figure S1 ). There was no evidence of interaction between asymptomatic infection and age (P > .2), nor was there evidence of violation of the proportional hazards assumption (P > .2). The final model, including subject as a random effect, adjusted for age and season, showed that presence of an asymptomatic P. falciparum infection between malaria illness episodes was associated with a 50% decrease in the risk of malaria illness (Table 3) . Neither clonality nor microscopic detectability altered this association (Supplementary Tables S1 and S2). 
Association Between Persistence of Infection and Clinical Symptoms
Of 1062 infected samples from enrollment and follow-up that were genotyped, 711 (67%) had results for at least 2 of the target alleles. Overall, MSP1, MSP2, and GLURP were amplified in 66%, 63%, and 64% of samples, respectively. Genotyping success was lowest among adults (56%), compared to under-5 children (69%) and SAC (70%). There were 503 unique genotypes detected, with no genotype comprising greater than 2% of observations. There were 179 clinical episodes preceded by asymptomatic infections, 95 (53%) with successful genotyping data from both infections. Of those 95 clinical episodes, 42 (44%) contained only new genotypes, 8 (8%) contained only genotypes persisting from the preceding asymptomatic infection, and 45 (47%) contained both newly-detected genotypes and persistent genotypes. There were 642 post-enrollment samples that could be classified as either only new (297, 46%), new and persistent (220, 34%), or only persistent (125, 19%) ( Table 4 ). The crude odds ratio for an infection with any newly-detected genotypes to be symptomatic compared to only persistent genotypes was 5.2 (95% confidence interval: 3.3, 8.3). The crude odds ratio for malaria illness with only new genotypes compared to any persistent genotype was 1.8 (95% confidence interval: 1.3, 2.4). There was no difference in the odds of malaria illness in people with only new genotypes compared to those with new and persistent genotypes (P = .87).
In final models for the association between any newly-detected infection and symptoms, while accounting for repeated measures among individuals, there was a statistically significant interaction between infection type and age (P = .04). Among children under 15, infection with any newly-detected genotype was associated with a 39% increase in the odds of that infection being symptomatic, compared to infections in which all genotypes were persistent (Table 5 ). For adults, odds of symptoms among those with only newly-detected genotypes were not different than the odds of symptoms among those with persistent genotypes (odds ratio = 0.93, 95% confidence interval: 0.85, 1.01).
DISCUSSION
We examined the association between asymptomatic P. falciparum infections and subsequent risk of malaria illness using genotyping, to establish whether asymptomatic infections eventually progress to malaria illness. We demonstrated that carriage of an asymptomatic P. falciparum infection was associated with a 50% decrease in the risk of malaria illness. Additionally, asymptomatic infections were unlikely to cause malaria illness without the appearance of a new P. falciparum genotype. Any newly-acquired P. falciparum infection, independent of concurrent persistent infections, increased the odds of malaria illness, particularly among children. This is the first study to use prospective, longitudinal detection of asymptomatic Plasmodium infections to examine subsequent risks of malaria illness among all ages. Our results are consistent with previous cross-sectional studies, in various transmission settings, that defined asymptomatic infections at a single time point to ascertain risk of subsequent malaria illness [4, [14] [15] [16] . Previous studies did not account for intermittent detectability of asymptomatic infections [17] [18] [19] , and many individuals categorized as "non-infected" in previous investigations would have been categorized as infected if additional sampling had been done. Our study design and analyses addressed this problem of potential misclassification by performing frequent sampling and by analyzing asymptomatic infections as a time-varying variable.
New infections determined by genotyping were significantly associated with an increased risk of disease, which fits with previous studies [20] and theories of acquired clinical immunity to P. falciparum. People are thought to develop immunity through acquisition of a repertoire of antibodies against key variable parasite surface antigens. Host responses, due to previous exposure to similar antigens, likely limit disease manifestations [21] . Upon infection with a parasite with surface antigens different from those previously encountered, symptomatic disease can occur. In our study, only 8% of malaria illnesses that followed asymptomatic infection had identical genotypes present during that preceding asymptomatic infection, suggesting that asymptomatic infections rarely progress to symptomatic malaria. This may be a result of changes in variant surface antigens expressed on the surface of infected erythrocytes [22] , or failure of the genotyping method to identify a unique clone. While it is possible that the genotyping method used failed to accurately differentiate unique infections, the diversity of genotypes identified suggest the probability is low, with no genotype comprising greater than 2% of observations. Our findings differ from 1 study in Uganda where 17% to 45% of paired asymptomatic infections and subsequent malaria illnesses shared identical genotypes [8] . Reasons for the differences in findings may be related to the prior study's (1) limited age group included (6 months to 5 years old), (2) definition of asymptomatic infection (including infections detected within 1 day of clinical symptoms), (3) lower infection prevalence (47% by PCR), and (4) genotyping using only MSP-2 (lacking MSP-1 and GLURP variants).
The odds of malaria illness did not increase when infections with only new genotypes were compared to those with both new and persistent genotypes, suggesting that there is not a direct protective effect of persistent infections. This finding adds weight to the recently published report that treatment of asymptomatic infections is unlikely to affect subsequent risk of disease [23] .
In our study, an increased risk of symptomatic disease due to newly-detected genotypes was significant only among children under age 15. While infections may have been newly detected among adults during our study, most adults probably have disease-protective immunity to both persistent and new infections. Additionally, the low incidence of malaria illness among adults over the course of the study limited our ability to detect an increase in risks from newly-acquired infections. The conclusions from our investigation are limited by poor sensitivity of the genotyping methods used. Using whole blood would have increased sensitivity, but would have required collecting blood via venipuncture. Given the frequency of sampling and the age range of participants, we elected to collect finger-prick samples on filter paper. The smaller blood volumes were likely the major reason why 34% of samples with PCRdetected infection were not genotyped successfully. Genotyping success was related to both parasite density and age: a lower proportion of asymptomatic infections were successfully genotyped compared to symptomatic infections. In addition, the use of gel rather than capillary electrophoresis might have decreased our sensitivity to detect all genotypes present in a sample [24] . However, these limitations likely biased results toward the null, potentially underestimating the true association, because we may not have detected persistent infections with low-density parasitemias in participants with simultaneous new, high-density parasitemia infections.
Persistent asymptomatic P. falciparum infections are common in southern Malawi and may be important drivers of transmission [25] , but they rarely develop into malaria illness. Asymptomatic infections were associated with an increased time between malaria illness episodes, independent of age or season. Previous hypotheses, suggesting that this was related to a protective effect of persistent infections, are not supported by our data. Once persistent asymptomatic infections were established, symptoms occurred following new infections with new parasite genotypes. Newly-acquired infections were more likely to lead to symptomatic disease, even in the presence of a persistent infection. These persistent, asymptomatic infections may simply be a marker of increasing host immunity to infections genetically similar to previous infections, and individuals who can maintain persistent asymptomatic infections also have decreased risk of disease. With additional studies that explore the mechanisms by which asymptomatic carriage increases the time between disease episodes, new insights into infection detection and transmission interruption will be possible. 
